EUVIMEDEUVIMED entdecken
Open Access

Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease

Rohan Palanki iD, Sourav K Bose, Apeksha Dave, Brandon M White, Cara Berkowitz, Valerie Luks, Fazeela Yaqoob, Emily Han, Kelsey L Swingle iD, Pallavi Menon, Emily Hodgson, Arijit Biswas und 16 weitere

ACS Nano · 25.07.2023 · 17 (14) · 13594-13610

DOI: 10.1021/acsnano.3c02268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 17.07.2023. Verfasst von Rohan Palanki und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Nanoparticles, Brain Diseases. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delivery of mRNA-based therapeutics to the perinatal brain holds great potential in treating congenital brain diseases. However, nonviral delivery platforms that facilitate nucleic acid delivery in this environment have yet to be rigorously studied. Here, we screen a diverse library of ionizable lipid nanoparticles (LNPs) via intracerebroventricular (ICV) injection in both fetal and neonatal mice and identify an LNP formulation with greater functional mRNA delivery in the perinatal brain than an FDA-approved industry standard LNP. Following in vitro optimization of the top-performing LNP (C3 LNP) for codelivery of an adenine base editing platform, we improve the biochemical phenotype of a lysosomal storage disease in the neonatal mouse brain, exhibit proof-of-principle mRNA brain transfection in vivo in a fetal nonhuman primate model, and demonstrate the translational potential of C3 LNPs ex vivo in human patient-derived brain tissues. These LNPs may provide a clinically translatable platform for in utero and postnatal mRNA therapies including gene editing in the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesBrain DiseasesMiceHumansAnimalsGene EditingLipidsLiposomesRNA, MessengerRNA, Small Interfering

Stichwörter der Autor:innen

congenital brain diseasefetal gene therapygene editingionizable lipid nanoparticlesmRNA delivery

Substanzen

Lipid NanoparticlesLipidsLiposomesRNA, MessengerRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Duke-NUS Graduate Medical School, Singapore, 169547, Singapore.
  • Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

ORCID-Profile: Rohan Palanki, Kelsey L Swingle, Margaret M Billingsley, Mohamad-Gabriel Alameh, Drew Weissman, Michael J Mitchell

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIH Office of the Director
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute
  • Burroughs Wellcome Fund

Zitieren

APA

Palanki, R., Bose, S. K., Dave, A., White, B. M., Berkowitz, C., Luks, V., Yaqoob, F., Han, E., Swingle, K. L., Menon, P., Hodgson, E., Biswas, A., Billingsley, M. M., Li, L., Yiping, F., Carpenter, M., Trokhan, A., Yeo, J., Johana, N., …, & Peranteau, W. H. (2023). Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease. ACS Nano, 17(14), 13594-13610. https://doi.org/10.1021/acsnano.3c02268

Vancouver

Palanki R, Bose SK, Dave A, White BM, Berkowitz C, Luks V, et al. Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease. ACS Nano. 2023;17(14):13594-13610. doi:10.1021/acsnano.3c02268

BibTeX
@article{Palanki2023,
  author = {Palanki, Rohan and Bose, Sourav K and Dave, Apeksha and White, Brandon M and Berkowitz, Cara and Luks, Valerie and Yaqoob, Fazeela and Han, Emily and Swingle, Kelsey L and Menon, Pallavi and Hodgson, Emily and Biswas, Arijit and Billingsley, Margaret M and Li, Li and Yiping, Fan and Carpenter, Marco and Trokhan, Alexandra and Yeo, Julie and Johana, Nuryanti and Wan, Tan Yi and Alameh, Mohamad-Gabriel and Bennett, Frederick Chris and Storm, Phillip B and Jain, Rajan and Chan, Jerry and Weissman, Drew and Mitchell, Michael J and Peranteau, William H},
  title = {Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {14},
  pages = {13594--13610},
  doi = {10.1021/acsnano.3c02268}
}
Kostenlos starten →